Binding blockade between TLN1 and integrin β1 represses triple-negative breast cancer.
Yixiao ZhangLisha SunHaonan LiLiping AiQingtian MaXinbo QiaoJie YangHao ZhangXunyan OuYining WangGuanglei ChenJinqi XueXudong ZhuYu ZhaoYongliang YangCaigang LiuPublished in: eLife (2022)
This study was supported by grants from the National Natural Science Foundation of China (No. 81872159, 81902607, 81874301), Liaoning Colleges Innovative Talent Support Program (Name: Cancer Stem Cell Origin and Biological Behaviour), Outstanding Scientific Fund of Shengjing Hospital (201803), and Outstanding Young Scholars of Liaoning Province (2019-YQ-10).